Contour+ (MVision AI Segmentation)

by MVision AI  · Based in Finland → — Automate Smarter, Treat Faster AI-powered platform for Radiotherapy
Oncology Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

Contour+ (MVision AI Segmentation) is an AI-powered auto-segmentation software designed to revolutionize radiation therapy treatment planning. It delivers fast and precise automatic delineation of organs-at-risk (OARs) and lymph node areas, adhering to international guidelines such as ESTRO, EPTN, RTOG, and the UK SABR Consortium.

The tool significantly reduces manual contouring work by up to 95% and boosts consistency by an average of 20% across different experts and clinics. This efficiency allows radiation oncology professionals to focus more on patient-facing tasks, reduce waiting lists, and provide faster access to treatment.

Contour+ offers comprehensive coverage with over 300 structures, including 159 organs-at-risk and 67 lymph node regions, across major anatomical sites like head and neck, breast, mediastinal, and pelvic areas. It features customizable advanced operations for modifying AI-generated contours, clinical flexibility for creating new ROIs and virtual structures, and seamless integration with existing DICOM-compliant radiotherapy treatment planning systems.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered auto-segmentation of OARs and lymph nodes
  • Guideline-based contouring (ESTRO, EPTN, RTOG, UK SABR Consortium)
  • Reduces manual contouring work by up to 95%
  • Boosts contouring consistency by 20%
  • Comprehensive anatomical coverage (300+ structures, 159 OARs, 67 LN regions)
  • Customizable advanced ROI operations and post-processing tools
  • Clinical flexibility for new ROIs and virtual structures
  • Seamless integration with DICOM-compliant TPS
  • Cloud-based and local (on-premises) deployment options
  • Supports CT and MR images

Use Cases

  • Radiation therapy treatment planning
  • Auto-contouring of organs-at-risk
  • Auto-contouring of lymph node regions
  • Standardizing contouring practices
  • Improving workflow efficiency in radiotherapy departments
  • Supporting clinical trials and cancer research

What Physicians Need to Know

Key Capabilities
Contour+ is an AI-powered auto-segmentation software for radiotherapy that provides fast and precise delineation of organs at risk and lymph node regions. It covers all major anatomical sites and includes models for over 300 structures, including 90 lymph node areas. The software is built in alignment with international contouring guidelines, such as ESTRO, EPTN, RTOG, and UK SABR Consortium. It can automatically generate 3D models of organs-at-risk and lymph nodes, reducing manual work by up to 95%. Contour+ also offers advanced ROI operations and smart post-processing options for customized volumes, including combining, subtracting, and adding structures, as well as detecting bony volumes and high-density materials. It supports MR-only workflows with models for brain (MR T1) and pelvis (MR T2), and a CBCT model for dose recalculation and offline adaptive replanning.
Clinical Utility
Contour+ aims to standardize and accelerate radiation oncology workflows. It helps reduce inter-user variability and boosts consistency in contouring by an average of 20%. Studies have shown significant time savings, with contouring time reduced by a median of 29% to 79%, and a maximum of 54% to 92%. One study reported a median time for MVision AI contour generation of 2.3 minutes, compared to 25 minutes for manual contouring. The tool has demonstrated high clinical acceptance, with 87% of radiation oncologists in one study scoring Contour+ as requiring minor or no editing. It has been shown to improve workflow efficiency, with median planning process turnaround times reduced by up to 9 working days for prostate cancer treatment. The use of Contour+ has also facilitated the implementation of advanced techniques like volumetric-modulated arc therapy (VMAT).
Integration Options
Contour+ is available as an out-of-the-box solution with flexible deployment options, including cloud-based or locally installed. It integrates seamlessly with all DICOM-compliant radiotherapy treatment planning systems. Cloud deployment allows for easy and fast updates of AI algorithms, while a local solution is available for stricter data protection regulations.
Compliance Status
Contour+ ensures complete data protection and privacy, adhering to both GDPR and HIPAA regulations. It is CE marked (CE 2797) as a medical device under EU MDR 2017/745. The product has also received FDA 510(k) clearance for various models in the U.S. market. Its Quality Management System (QMS) for manufacturing is ISO 13485 and MDSAP certified. Contour+ has received market approval in Singapore, Morocco, the United Arab Emirates, and South Korea.
User Experience
The tool is designed to be intuitive and adaptable, enhancing patient care without disrupting existing workflows. Studies indicate that the time for manually adjusting MVision AI contours did not differ based on physicians' experience, suggesting it is equally helpful for all users. Overall, 87% of radiation oncologists in one study found Contour+ to require minor or no editing. The median time for manual corrections after AI generation was 10 minutes.
Implementation Complexity
Successful AI adoption requires clinical oversight, thoughtful integration into existing systems, and continuous investment in training and education. The system integrates seamlessly with any DICOM-compliant treatment planning system and requires no local tuning.
Evidence Base
MVision AI Contour+ has been extensively evaluated in independent studies across multiple institutions and countries. A series of studies published in peer-reviewed journals evaluated its performance and impact on clinical practice, involving 17 clinics across 12 countries, with 64 evaluators assessing 16,454 volumes of interest on 1,242 scans. These studies were not financially supported by MVision, ensuring unbiased results. The research covers accuracy, clinical acceptability, time savings, dosimetric impact, and workflow efficiency. The HARMONY study, a multi-institutional international study, demonstrated time and consistency benefits for head and neck radiotherapy. Another study showed that 78% of cases using the ESTRO-based MVision Contour+ model enabled clinical use after only minor or no adjustments. The tool has been used for treating over 170,000 cancer patients in 16 countries.
Physician Tip

Contour+ can significantly reduce contouring time and improve consistency in radiotherapy planning. While the AI-generated contours are highly accurate, always review and make minor adjustments as needed to ensure optimal patient care. The tool's adherence to international guidelines can help standardize practices across your department. Consider utilizing the accompanying Guide and Verify tools for continuous education and quality assurance, especially for training junior staff. The flexibility of cloud-based or local deployment allows for integration into various clinical environments.

Contour+ is designed for seamless integration with all DICOM-compliant radiotherapy treatment planning systems. It can be deployed either as a cloud-based solution for easy updates or as a locally installed system to meet specific data protection requirements. The broader MVision AI GBS™ solution also includes Guide and Verify, which can be integrated for a comprehensive approach to AI radiotherapy contouring, verification, and education.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Contact for pricing
DeploymentPlatform (Workspace+)
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Oncology, Radiology

Support & Reliability

FDA clearance history

Each FDA authorization for this product and its earlier versions, newest first. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2024-10-18K241490 510(k)Contour+ (MVision AI Segmentation)
2022-05-03K212915 510(k)MVision AI Segmentation

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Contour+ (MVision AI Segmentation)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Contour+ (MVision AI Segmentation).

View all on YouTube

Frequently Asked Questions

Contour+ is designed for seamless integration into existing radiotherapy treatment planning systems, utilizing standard DICOM protocols. It can be deployed as a cloud-based solution, allowing for easy updates, or as a local solution for stricter data protection requirements. This flexibility ensures compatibility with various clinical environments without requiring complex local hardware installations.
While Contour+ significantly automates organ-at-risk and lymph node contouring, the definition of Gross Tumor Volume (GTV) and Clinical Target Volume (CTV) remains physician-led due to the need for personalized clinical factors. All AI-generated contours require verification by a radiation oncologist, especially for target volumes or organs at risk in close proximity to them. Over-reliance on AI accuracy without critical evaluation could lead to missed errors.
MVision AI prioritizes data protection and privacy, adhering to both GDPR and HIPAA regulations. Patient scans are encrypted and pseudonymized before being sent to the MVision AI cloud for processing, and personal data (PHI) never leaves the hospital's IT systems in a fully compliant workflow. The clinic remains the data controller, and MVision AI acts as the data processor, with scans deleted from the cloud within 24 hours after segmentation.
Several other AI auto-contouring solutions are available, including Radformation AutoContour, Limbus Contour, Siemens AI-Rad Companion Organs RT, RayStation DLS, and MIM ProtégéAI+. The best fit often depends on your existing treatment planning system, imaging modalities, and specific workflow needs.
Contour+ automates the delineation of organs-at-risk and lymph node areas, generating precise 3D models in minutes, which can save hours of manual work. This efficiency allows clinicians to focus more on patient-facing tasks and can reduce waiting lists. Studies have shown that it can reduce contouring time by a median of 29% to 79%, with some clinics experiencing up to a 9-day reduction in planning process turnaround times for prostate cancer treatment.
Contour+ generates high-quality contours, with independent studies reporting median Dice Similarity Coefficients (DSC) of 0.87 to 0.88 for various anatomical structures. Clinicians have generally shown high acceptance, with many contours requiring only minor or no edits; one study indicated 87% of contours were considered 'well done' or 'very well done'. However, physician oversight is always required to verify and, if necessary, modify the AI-generated contours to ensure clinical accuracy and patient safety.
Contour+ uses AI models trained on international guidelines, such as ESTRO and RTOG, to ensure standardized and consistent contours. While it provides a guideline-based foundation, the contours come in pre-defined models that can be further configured to fit within each clinic's specific protocols. This allows for alignment with local clinical preferences, including fine-tuning structures like lymph nodes through advanced operations.

Related Tools

VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464)
Spectrum Dynamics Medical
Oncology AI
The VERITON CT 400 Series is a digital SPECT/CT system with a 360-degree gantry and 12 swiveling CZT detectors, offering high sensitivity and quantitative accuracy for a wide range of nuclear medicine applications, including advanced theranostics imaging.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
BIOGRAPH One
Siemens Healthineers AG
Oncology AI
BIOGRAPH One is a second-generation PET/MR scanner designed to transform PET/MR image quality for a new era, combining high PET precision with powerful MR performance. It enables simultaneous visualization of organ location, function, and cellular metabolism, offering faster image acquisition times and more efficient workflows than previous generations of PET/MR scanners.
Claire™ OCT System
Perimeter Medical Imaging AI
Oncology AI
Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultra-high resolution, real-time, advanced imaging tools that address unmet medical needs.S. for intraoperative breast cancer margin assessment.
syngo.via RT Image Suite VC10
Varian Medical Systems, Inc.
Clinical Decision Support & Reference
syngo.via RT Image Suite VC10 offers advanced imaging and workflow solutions for precise and efficient radiation therapy planning.

See all Oncology AI tools →

More from MVision AI

Dose+
MVision AI
Oncology AI
Dose+ is an AI-powered software for dose prediction and personalized radiotherapy treatment planning, specifically designed to optimize prostate and pelvic lymph node radiotherapy workflows.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-10 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.